Ixosin (1-18)
General Information
DRACP ID DRACP02865
Peptide Name Ixosin (1-18)
Sequence GLHKVMREVLGYERNSYK
Sequence Length 18
UniProt ID Q2LKX9
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | 13% Killing>128 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity HEK-293: 6% Killing>128 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C96H155N29O27S
Absent amino acids ACDFIPQTW
Common amino acids EGKLRVY
Mass 248292
Pl 9.93
Basic residues 5
Acidic residues 2
Hydrophobic residues 4
Net charge 3
Boman Index -4739
Hydrophobicity -93.33
Aliphatic Index 75.56
Half Life
Mammalian: 2.8 hour
Yeast: 10 min
E.coli: 2 min
Extinction Coefficient cystines 2980
Absorbance 280nm 175.29
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 27622949
Title Central Role of the Copper-Binding Motif in the Complex Mechanism of Action of Ixosin: Enhancing Oxidative Damage and Promoting Synergy with Ixosin B
Doi 10.1021/acsinfecdis.5b00140
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPR_17324